Patents by Inventor Robert V. TIGHE, III

Robert V. TIGHE, III has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190031785
    Abstract: Provided herein are multispecific immunomodulatory antigen-binding constructs (MIACs) and compositions comprising the constructs. Also provided are methods of using the constructs and methods of making the constructs.
    Type: Application
    Filed: January 13, 2017
    Publication date: January 31, 2019
    Inventors: Thomas Joseph SCHUETZ, Piotr BOBROWICZ, Helen SABZEVARI, Michael March SCHMIDT, Robert V. TIGHE, III, Simon METENOU
  • Publication number: 20190015508
    Abstract: The present disclosure relates to, inter alia, compounds (e.g., antibodies, or antigen-binding fragments thereof) that bind to an epitope of CD137 and agonize CD137, and to use of the compounds in methods for treating, or ameliorating one or more symptoms of, cancer.
    Type: Application
    Filed: September 6, 2018
    Publication date: January 17, 2019
    Inventors: Piotr Bobrowicz, Paul Widboom, Michael March Schmidt, Jason M. Lajoie, Robert V. Tighe, III, Cheuk Lun Leung, Ugur Eskiocak
  • Publication number: 20180318417
    Abstract: Provided herein are multispecific immunomodulatory antigen-binding constructs (MIACs) and compositions comprising the constructs. Also provided are methods of using the constructs and methods of making the constructs.
    Type: Application
    Filed: January 13, 2016
    Publication date: November 8, 2018
    Inventors: Thomas Joseph SCHUETZ, Piotr BOBROWICZ, Helen SABZEVARI, Michael March SCHMIDT, Robert V. TIGHE, III, Simon METENOU